https://youtu.be/lgZbRvQfhPg
Grizzle identified Compass Pathways as our conviction call IPO, our primer laid out the opportunity (Sept 18/2020).
The stock... Read More»
Grizzle sits down with Terry Chong (Partner, Grizzle Ventures) to discuss one of the most anticipated IPOs in the psychedelic sector: Compass Pathways (NASD:CM... Read More»
Grizzle had the pleasure of sitting down with the CEO of MindMed - JR Rahn.
Terry Chong leads an in-depth and insightful interview with JR, Terry is a vetera... Read More»
https://youtu.be/umHhVOJd_Yo
Thomas George and Terry Chong talk about the process of drug approval and MindMed in the second episode of the Grizzle Psychedel... Read More»
https://youtu.be/83WJSRfpPCI
Thomas George, Eddie DaRoza, and Scott Willis talk mind altering drugs in our inaugural episode of the Grizzle Psychedelics seri... Read More»
Researchers at the University of Auckland in New Zealand have gained approval to study the effects of microdosing LSD on the human brain.
A team led by Dr. S... Read More»
The National Institute of Mental Health is bringing in psychedelics expert Dr. Roland Griffiths to give a talk on the neuropharmacology of psilocybin.
Griffi... Read More»